G. Duru

1.7k total citations
43 papers, 1.3k citations indexed

About

G. Duru is a scholar working on Epidemiology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, G. Duru has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in G. Duru's work include Cutaneous Melanoma Detection and Management (7 papers), Migraine and Headache Studies (7 papers) and Nonmelanoma Skin Cancer Studies (7 papers). G. Duru is often cited by papers focused on Cutaneous Melanoma Detection and Management (7 papers), Migraine and Headache Studies (7 papers) and Nonmelanoma Skin Cancer Studies (7 papers). G. Duru collaborates with scholars based in France, United States and United Kingdom. G. Duru's co-authors include Nicolas Nicoloyannis, Pascal Chanez, Philippe Godard, L. Thomas, Stéphane Dalle, P. Henry, G Chazot, Michel Lantéri‐Minet, Christian Lucas and J. P. Auray and has published in prestigious journals such as Neurology, Clinical Infectious Diseases and Social Science & Medicine.

In The Last Decade

G. Duru

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Duru France 16 386 376 285 249 248 43 1.3k
Claire Le Jeunne France 24 250 0.6× 143 0.4× 206 0.7× 184 0.7× 273 1.1× 122 1.5k
Liora Ore Israel 17 79 0.2× 88 0.2× 127 0.4× 608 2.4× 228 0.9× 39 2.0k
Nilgün Erten Türkiye 17 821 2.1× 169 0.4× 124 0.4× 82 0.3× 87 0.4× 63 1.5k
Sean McElligott United States 12 184 0.5× 41 0.1× 156 0.5× 61 0.2× 113 0.5× 26 1.0k
Rita Wickham United States 16 127 0.3× 82 0.2× 66 0.2× 71 0.3× 220 0.9× 38 1.1k
Carmen P. Escalante United States 20 73 0.2× 143 0.4× 72 0.3× 57 0.2× 387 1.6× 51 1.8k
Gregory P. Hess United States 24 95 0.2× 75 0.2× 200 0.7× 78 0.3× 183 0.7× 83 1.7k
Jamie N. Brown United States 19 81 0.2× 92 0.2× 76 0.3× 72 0.3× 89 0.4× 69 911
Minesh Khatri United States 11 173 0.4× 113 0.3× 206 0.7× 35 0.1× 201 0.8× 13 1.1k
F. Rétornaz France 17 222 0.6× 84 0.2× 70 0.2× 44 0.2× 121 0.5× 98 991

Countries citing papers authored by G. Duru

Since Specialization
Citations

This map shows the geographic impact of G. Duru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Duru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Duru more than expected).

Fields of papers citing papers by G. Duru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Duru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Duru. The network helps show where G. Duru may publish in the future.

Co-authorship network of co-authors of G. Duru

This figure shows the co-authorship network connecting the top 25 collaborators of G. Duru. A scholar is included among the top collaborators of G. Duru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Duru. G. Duru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duru, G., Stéphane Nancey, Jean–Marc Phelip, et al.. (2023). P325 Proton pump inhibitors are associated with a disabling course of Crohn’s disease. Journal of Crohn s and Colitis. 17(Supplement_1). i464–i465. 1 indexed citations
2.
Amini‐Adlé, Mona, et al.. (2018). Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma. BMC Cancer. 18(1). 705–705. 17 indexed citations
3.
Paul, Stéphane, G. Duru, Annick de Vries, et al.. (2017). P226 Comparison of four different immunoassays for measuring golimumab and anti-golimumab antibody concentration in patients with ulcerative colitis. Journal of Crohn s and Colitis. 11(suppl_1). S192–S192. 2 indexed citations
4.
Poulalhon, Nicolas, et al.. (2012). Dermoscopy use by French private practice dermatologists: a nationwide survey. British Journal of Dermatology. 168(1). 74–79. 22 indexed citations
5.
6.
Ronger-Savlé, S., et al.. (2010). Features of pigmented vulval lesions on dermoscopy. British Journal of Dermatology. 164(1). 54–61. 56 indexed citations
7.
Just, J., et al.. (2008). Lack of eosinophilia can predict remission in wheezy infants?. Clinical & Experimental Allergy. 38(5). 767–773. 43 indexed citations
8.
Bernard, Philippe, et al.. (2008). Basal Cell Carcinomas and Actinic Keratoses Seen in Dermatological Practice in France: A Cross-Sectional Survey. Dermatology. 216(3). 194–199. 34 indexed citations
9.
Bernard, Philippe, A. Dupuy, P. Brun, et al.. (2007). Évaluation médico-économique de la prise en charge des carcinomes basocellulaires superficiels et des kératoses actiniques multiples par les dermatologues français. Annales de Dermatologie et de Vénéréologie. 134(6-7). 527–533. 7 indexed citations
10.
Debarbieux, S., G. Duru, Stéphane Dalle, et al.. (2007). Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. British Journal of Dermatology. 157(1). 58–67. 72 indexed citations
11.
Mourad, Jean‐Jacques, et al.. (2004). Comparison of different therapeutic strategies in hypertension. Journal of Hypertension. 22(12). 2379–2386. 79 indexed citations
12.
Pradalier, A, Jean‐Paul Auray, Abdelkader El Hasnaoui, et al.. (2004). Economic Impact of Migraine and Other Episodic Headaches in France. PharmacoEconomics. 22(15). 985–999. 68 indexed citations
13.
14.
Henry, P., J. P. Auray, J.F. Dartigues, et al.. (2002). Prevalence and clinical characteristics of migraine in France. Neurology. 59(2). 232–237. 210 indexed citations
15.
Duru, G., et al.. (2002). Limitations of the Methods Used for Calculating Quality-Adjusted Life-Year Values. PharmacoEconomics. 20(7). 463–473. 37 indexed citations
16.
Godard, Philippe, et al.. (2001). Costs of asthma are correlated with severity: a 1-yr prospective study. European Respiratory Journal. 19(1). 61–67. 257 indexed citations
17.
Ament, André J.H.A., Rob Baltussen, G. Duru, et al.. (2000). Cost-Effectiveness of Pneumococcal Vaccination of Older People: A Study in 5 Western European Countries. Clinical Infectious Diseases. 31(2). 444–450. 110 indexed citations
18.
Lepape, Alain, et al.. (1999). Le concept de dose définie journalière (DDD) appliqué au suivi des consommations d'antibiotiques dans deux services de réanimation. Journal de Pharmacie Clinique. 17(4). 211–217. 3 indexed citations
19.
Danzon, Arlette, et al.. (1988). [Modalities of the care of acute non-severe infantile diarrhea as a function of the place of care. Prospective study during a winter epidemic].. PubMed. 45(5). 369–72. 2 indexed citations
20.
Auray, J. P., et al.. (1985). On the choice of an organization for a pathology laboratory. Social Science & Medicine. 21(10). 1113–1118. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Le Jeunne Breakdown of academic impact, for papers by Liora Ore Breakdown of academic impact, for papers by Nilgün Erten Breakdown of academic impact, for papers by Sean McElligott Breakdown of academic impact, for papers by Rita Wickham Breakdown of academic impact, for papers by Carmen P. Escalante Breakdown of academic impact, for papers by Gregory P. Hess Breakdown of academic impact, for papers by Jamie N. Brown Breakdown of academic impact, for papers by Minesh Khatri Breakdown of academic impact, for papers by F. Rétornaz
Rankless by CCL
2026